Posted by Michael Wonder on 23 Sep 2020
Instrumentation Laboratory receives US FDA marketing authorisation for the first apixaban diagnostic test
22 September 2020 - The first direct oral anticoagulant test authorised for clinical use on automated hemostasis systems.
Instrumentation Laboratory announced today that the US FDA granted De Novo marketing authorisation for the HemosIL Liquid Anti-Xa test kit to measure apixaban.
This is the first direct oral anticoagulant test for automated hemostasis analysers authorised by the FDA.
